Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $535,668 - $708,818
-4,106 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $600,379 - $694,447
4,106 New
4,106 $608,000
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $809,540 - $1 Million
-6,800 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $727,056 - $900,524
6,800 New
6,800 $894,000
Q2 2019

Aug 13, 2019

SELL
$110.79 - $129.32 $14.3 Million - $16.7 Million
-129,404 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$111.31 - $131.02 $14.4 Million - $17 Million
129,404 New
129,404 $16.8 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Athanor Capital, LP Portfolio

Follow Athanor Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Athanor Capital, LP with notifications on news.